Capital Goods M&A and Valuation: Cyclical Adjustments and Platform Premiums

Introduction

Capital goods valuation is the most analytically complex area within industrials banking because it requires two overlapping adjustments that do not exist in most other sectors. First, cyclical normalization adjusts the earnings base from wherever the company currently sits in the cycle to a mid-cycle level that represents sustainable earning power. Second, business quality differentiation applies the right multiple to that normalized earnings base, recognizing that the capital goods universe spans from commodity OEMs (8-12x) to operational excellence platforms (18-25x), a wider spread than in virtually any other sub-sector.

Getting both adjustments right is the central challenge of capital goods deal execution. Normalize too aggressively, and you undervalue a business that is genuinely growing above trend due to secular tailwinds. Normalize too conservatively, and you overvalue a business whose peak earnings are unsustainable. Apply the wrong multiple tier, and you either leave money on the table for sellers or overpay for buyers. This article synthesizes the frameworks from the preceding articles in this section into a unified valuation approach for capital goods M&A.

The first step in any capital goods valuation is determining where the company's current earnings sit relative to mid-cycle. This requires assessing three dimensions simultaneously.

Where is the macro cycle? Use leading indicators (ISM PMI, capacity utilization, housing starts, durable goods orders) to assess where the economy currently sits. If the ISM PMI is above 54 and capacity utilization exceeds 80%, the economy is likely in a mid-to-late expansion, and capital goods earnings are at or above mid-cycle levels. If the PMI is below 48 and utilization is below 75%, earnings are likely below mid-cycle.

Where is the company's specific end market? A capital goods company may be out of sync with the broader economy if its specific end markets are in a different cycle phase. A construction equipment manufacturer could be experiencing peak demand from infrastructure spending even while the broader manufacturing economy is in contraction. The early/mid/late cycle classification of the company's end markets matters more than the headline macro data.

Is the company experiencing any secular growth? If a meaningful portion of the company's growth is driven by secular tailwinds (electrification, automation, reshoring) rather than cyclical expansion, the normalization adjustment should be smaller because the secular component will persist through a downturn. Conversely, if the company's growth is entirely cyclical, the normalization should be more aggressive.

Cyclical Adjustment in Capital Goods Valuation

The process of adjusting a capital goods company's reported EBITDA to estimate what it would earn at a "normal" point in the economic cycle, accounting for operating leverage effects that amplify revenue changes into larger earnings changes. The three standard methods are: historical averaging (mean EBITDA across 5-7 years), margin regression (applying a mid-cycle margin to current revenue), and capacity utilization adjustment (calibrating margins to a normal utilization rate). In M&A, sellers argue that current earnings are sustainable or below mid-cycle, while buyers argue they are above mid-cycle. The negotiation often centers on the normalization methodology.

Once the normalized earnings base is established, the second step is selecting the appropriate multiple. In capital goods, the multiple range is extraordinarily wide, driven by the business quality factors outlined throughout this section of the guide.

The 20x+ multiples at the top of the range may seem extreme for "industrial" companies, but they reflect genuine economic differentiation. A company like Roper Technologies generates 35-40% EBITDA margins, converts over 100% of net income to free cash flow, grows organically at rates exceeding GDP, and has a demonstrated operating system that improves every acquisition. These characteristics produce long-duration, compounding free cash flow streams that the market appropriately values at technology-like multiples.

Capital goods M&A is characterized by intense competition between strategic acquirers and PE sponsors for the best assets. Understanding how each buyer type approaches valuation is critical for running effective sell-side processes.

Strategic acquirers can pay more because they underwrite synergies and operating system improvements. When Parker Hannifin evaluates a specialty filtration company, it underwrites 200-300bp of margin improvement from the Win Strategy operating system, plus cost synergies from procurement consolidation and SG&A elimination. These improvements allow Parker to bid 14-16x trailing EBITDA (or 12-14x post-improvement EBITDA) and still generate attractive returns on invested capital. A PE sponsor, which must value the business on standalone economics without operating system benefits, typically cannot match this price.

PE sponsors compete through leverage and multiple arbitrage. While PE sponsors generally cannot match strategic multiples on the most premium assets, they dominate the middle-market where thousands of smaller capital goods businesses change hands. PE firms acquire platforms at 8-10x EBITDA, execute bolt-on acquisitions at 5-7x, and build scale that eventually attracts strategic acquirers willing to pay 12-16x at exit. The value creation comes from the spread between bolt-on entry multiples and platform exit multiples, not from the ability to pay the highest price on any single acquisition.

The sell-side banker's role is to create competitive tension between these buyer types. In a well-run process, the presence of PE sponsors establishes a floor price (based on standalone leveraged returns), while strategic acquirers bid above that floor based on synergy value. The banker's ability to quantify and present the synergy potential credibly (through detailed cost and revenue synergy analyses) directly influences whether strategics bid to their full capacity. A banker who presents a generic CIM attracts generic bids. A banker who presents a tailored investment thesis for each major strategic buyer, showing specific synergy pathways and operating improvement potential, extracts the maximum strategic premium.

Capital goods generates M&A activity across every quality tier, though the character and frequency of deal flow differ by tier.

At the premium tier, operational excellence platforms like Danaher, Roper, and AMETEK are active acquirers, each completing multiple transactions per year. Their acquisitions target businesses with margin improvement potential where the operating system can create value. These transactions generate buy-side advisory mandates and, when the acquired business was previously PE-owned, sell-side mandates as well. Competition among these acquirers for the best targets pushes transaction multiples to 14-20x, well above what PE sponsors can typically pay.

At the mid-tier, PE roll-ups in specialty components and business services generate the highest volume of individual transactions. These are the bread-and-butter deals for industrials bankers at middle-market firms: sell-side processes for PE portfolio exits, bolt-on acquisition advisory for growing platforms, and financing mandates for leveraged transactions.

At the OEM tier, deal activity is dominated by conglomerate divestitures and portfolio reshaping. When Honeywell splits into three companies, when Emerson divests its climate technologies segment for $14 billion, or when 3M spins off its healthcare business, the resulting carve-out transactions generate the largest individual advisory fees in capital goods. These deals are complex (standalone financial preparation, transition services, regulatory approvals) and require the resources of bulge bracket banks.

In capital goods, deal timing is not just about market conditions. It is about the interaction between the company's cycle position and the seller's exit objectives.

Selling at mid-to-peak cycle maximizes absolute EBITDA but requires the sell-side banker to defend the sustainability of current earnings. Buyers will scrutinize whether trailing EBITDA is at or above mid-cycle and may apply a "peak discount" (reducing the offered multiple to reflect expected future earnings compression). The banker must present compelling evidence that earnings are sustainable, using the normalization tools discussed above and, where applicable, demonstrating secular growth components that will persist through a downturn.

Selling at early-cycle recovery can actually produce attractive outcomes if the banker positions the narrative correctly. The trailing EBITDA is clearly below mid-cycle, which limits the absolute transaction value, but the demonstrated earnings recovery trajectory provides buyers with confidence in the growth story. The buyer is effectively purchasing the recovery and paying a current-year multiple that looks high but is reasonable on a forward or mid-cycle basis. This timing works best when leading indicators strongly support continued recovery.

Selling at cycle trough is generally the worst timing for a sell-side but may be forced by PE fund lifecycle constraints (the holding period has expired) or by distress. In these situations, the banker's job is to demonstrate that trough earnings understate normalized earning power and to frame the investment thesis around the recovery trajectory. Selling at trough often favors PE buyers who are willing to time the cycle and hold through recovery, since strategic acquirers may be cautious about cyclical risk.

Capital goods M&A is increasingly global. European industrial companies (Siemens, Schneider Electric, ABB) are active acquirers of US businesses, and US companies (Emerson, Parker Hannifin) acquire European targets to expand geographic reach. Cross-border transactions add currency, regulatory, and cultural complexity but also expand the buyer universe and can produce premium valuations when a US target fills a strategic gap in a European acquirer's portfolio.

The European capital goods landscape offers both parallels and differences. European industrial companies tend to be more globally diversified but sometimes trade at modest discounts to US peers due to lower growth rates, different market structures, and less aggressive capital allocation strategies. CRH's decision to move its primary listing from London to New York (and its subsequent inclusion in the S&P 500) reflected the valuation premium that US-listed industrials command, a dynamic that drives some cross-border M&A activity as European companies seek to access US capital markets pricing.

For bankers, cross-border capital goods transactions require additional analytical layers. Currency risk must be modeled (a US acquirer buying a European target faces EUR/USD exposure that affects both the acquisition price and the ongoing earnings contribution). Regulatory approvals may include EU competition review in addition to US HSR filing. Tax structuring becomes more complex with cross-border holding structures, transfer pricing, and differing depreciation rules. And cultural integration challenges, while less quantifiable, are real: the management cadences, decision-making processes, and operating philosophies of US and European industrial companies can differ significantly, affecting post-close integration success.

Capital goods transactions sometimes employ deal structures that address the cyclical uncertainty unique to the sector.

Earnouts and contingent consideration. When the buyer and seller disagree on whether current earnings are at peak, mid-cycle, or trough, an earnout can bridge the gap. The seller receives a guaranteed base price (reflecting the buyer's conservative normalization) plus contingent payments tied to the company's financial performance over 1-3 years post-close. If earnings prove sustainable (supporting the seller's thesis), the contingent payments trigger. If earnings compress (supporting the buyer's thesis), the contingent payments are reduced or forfeited. Earnouts are more common in capital goods M&A than in sectors with more stable earnings because the cyclical uncertainty creates a wider valuation gap to bridge.

Working capital adjustments. Capital goods companies carry significant working capital (inventory, receivables, payables) that fluctuates with the cycle. The purchase agreement typically specifies a normalized working capital target, and the seller receives an adjustment payment (positive or negative) based on actual working capital at closing relative to the target. Setting the appropriate working capital target requires analyzing the company's working capital across the full cycle, not just at the trailing twelve-month level, because working capital at a cyclical peak (high inventory, large receivables) differs substantially from working capital at a trough.

Locked-box vs. completion accounts. European capital goods transactions more commonly use locked-box mechanisms (where economic transfer occurs at a reference date before signing, with the buyer receiving all economics from that date forward) rather than the completion accounts approach standard in US transactions. Bankers executing cross-border deals must understand both mechanisms and their implications for price adjustment and risk allocation.